Fig. 4From: Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcomeDifferences between cytokines after tocilizumab, steroids, and anti-viral drugs treatment. Hydroxychloroquine has been added in the anti-viral group. Data are represented as median (IQR). **p < 0.05 vs. steroidsBack to article page